InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the complete record of transactions filed by Carroll David Francis, Chief Financial Officer. Director active across 1 companies, notably IVERIC bio, Inc.. Aggregated, 13 reports have been logged. Total volume traded: €1.6m. The latest transaction was disclosed on 1 April 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
€32,9182,144 shares@ €15.35352.0% of flow
Common Stock
SEC:0001410939-22-000046:0·
€22,07716,763 shares@ €1.3171.3% of flow
Common Stock
SEC:0001410939-22-000033:0·
€10,7618,237 shares@ €1.30640.6% of flow
Common Stock
SEC:0001410939-22-000024:0·
32,500 shares
Common Stock
SEC:0001104659-22-000976·
32,500 shares
Common Stock
SEC:0001104659-22-000976:0·
€796,57156,207 shares@ €14.1721100.0% of flow
Common Stock
SEC:0001104659-21-153088·
€796,57156,207 shares@ €14.172148.0% of flow
Common Stock
SEC:0001104659-21-153088:0·
14,375 shares
Common Stock
SEC:0001104659-21-152294·
14,375 shares
Common Stock
SEC:0001104659-21-152294:0·
12,500 shares
Common Stock
SEC:0001104659-21-149632·
12,500 shares
Common Stock
SEC:0001104659-21-149632:0·
10,000 shares
Common Stock
SEC:0001104659-21-149245·
10,000 shares
Common Stock
SEC:0001104659-21-149245:0·
13 of 13 declarations
About Carroll David Francis
Carroll David Francis serves as Senior Vice President, Chief Financial Officer, and Treasurer at IVERIC bio, Inc. He is responsible for the company's financial management, including financial planning, treasury, and financial reporting. With extensive experience in the biopharmaceutical sector, he plays a key role in optimizing financial performance and the company's investment strategy.
